Imricor touts MRI-guided cardiac ablation study data
Imricor Medical Systems this week released results from a clinical study of its Vision-MR ablation catheter designed for treating atrial flutter under real-time MRI guidance.
Results from the study were released at the annual meeting of the Heart Rhythm Society in Boston.
Data in the study came from 35 patients enrolled at Germany’s University of Leipzig Heart Center, with Dr. Gerhard Hindricks acting as the principle investigator. Results from the trial are slated to support the CE Mark approval application for clearance in the European Union, Imricor Medical said.
The company’s Vision-MR ablation catheter, intended for use with the Advantage-MR EP recorder and stimulator system, is designed to aid physicians in performing cardiac ablations with MRI guidance radiation free. The system provides lesion visualization and verification, and allows for the real-time assessment of cardiac substrate, according to a press release.